Alexandria Real Estate Equities traded at $46.42 this Tuesday March 31st, increasing $0.13 or 0.28 percent since the previous trading session. Looking back, over the last four weeks, Alexandria Real Estate Equities gained 11.80 percent. Over the last 12 months, its price fell by 49.07 percent. Looking ahead, we forecast Alexandria Real Estate Equities to be priced at 44.66 by the end of this quarter and at 40.76 in one year, according to Trading Economics global macro models projections and analysts expectations.
Alexandria Real Estate Equities, Inc. is a real estate investment (REIT). The Company is engaged in the business of providing space for lease to the life science and technology industries. It focuses on collaborative life science and technology campuses. It develops urban cluster campuses and ecosystems. Its properties are located in various areas, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland and Research Triangle Park. Its properties include Alexandria Center for Life Science South San Francisco; Alexandria Center for Life Science San Carlos, and Alexandria Center for Life Science Long Island City. Its asset base consisted of approximately 36.7 million and rentable square feet of operating properties and 3.4 million rentable square feet of Class A properties undergoing construction, 7.7 million rentable square feet of near-term and intermediate-term development and redevelopment projects, and 10.3 million feet of future development projects